Commission Regulation (EU) 2018/782 [Commission Regulation (EU) 2018/782 of 29 May 2018 establishing the methodological principles for the risk assessment and risk management recommendations referred to in Regulation (EC) No 470/2009 (OJ L 132, 30.5.2018, p. 5, ELI: http://data.europa.eu/eli/reg/2018/782/oj).] establishes the methodological principles for the risk assessment and risk management recommendations to be applied by EMA when preparing opinions on the MRLs. Section I.7 of Annex I to Regulation (EU) 2018/782 was amended by Commission Regulation (EU) 2025/1101 [Commission Regulation (EU) 2025/1101 of 3 June 2025 amending Regulation (EU) 2018/782 concerning the assessment by the European Medicines Agency of maximum residue limits for chemical-unlike biological substances (OJ L 2025/1101, 4.6.2025, ELI: http://data.europa.eu/eli/reg/2025/1101/oj).] to introduce a requirement for EMA to determine whether for a given chemical-unlike biological substance a classification ‘no MRL required’ is appropriate.
Recital 3, Regulation (EU) 2025/1103
In forcesince 3 Jun 2025